Atlas Trials

Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients

Clinical trial NCT02953873 · COMPLETED

Trial details

NCT number
NCT02953873
Sponsor
Medical University of South Carolina
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Immunosuppression
Start date
2017-05-05
Primary completion
2018-09-10
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.